Adiposity indices in the prediction of metabolic abnormalities associated with cardiovascular disease in non-diabetic adults

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 8, 2011, Pages 553-560

  Liu, A ^a   Abbasi, F ^a   Reaven, G M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Insulin resistance; Metabolic risk; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTOR; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79961128408     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.12.009     Document Type: Article

References (30)

1. Flegal K., Graubard B., Williamson D., Gail M. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037.
2. Rimm E., Stampfer M., Giovannucci E., Ascherio A., Spiegelman D., Colditz G., et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995, 141:1117-1127.
3. Alberti K., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diab Med 2006, 23:469-480.
4. Cleeman J. Executive summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
5. Ford E., Mokdad A., Giles W. Trends in waist circumference among US adults. Obes Res 2003, 11:1223-1231.
6. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M., Overvad K., et al. General and abdominal adiposity and risk of death in Europe. New Engl J Med 2008, 359:2105-2120.
7. Hu G., Tuomilehto J., Silventoinen K., Barengo N., Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged finnish men and women. Eur Heart J 2004, 25:2212-2219.
8. Reaven G.M. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am 2008, 37:581-601. [vii-viii].
9. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl. 1):S62-S67.
10. Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey (NHANES III 1988-94). Reference Manuals and Reports Bethesda, National Center for health Statistics 1996 (CD-ROM).
11. Grundy S., Cleeman J., Daniels S., Donato K., Eckel R., Franklin B., et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Am Heart Assoc 2005, 2735-2752.
12. Pei D., Jones C., Bhargava R., Chen Y., Reaven G. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 1994, 37:843-845.
13. Greenfield M., Doberne L., Kraemer F., Tobey T., Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981, 30:387-392.
14. Shen S.W., Reaven G.M., Farquhar J.W. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970, 49:2151-2160.
15. Facchini F., Hua N., Abbasi F., Reaven G. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001, 86:3574-3578.
16. Yip J., Facchini F., Reaven G. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998, 83:2773-2776.
17. Farin H., Abbasi F., Reaven G. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 2006, 83:47-51.
18. Canoy D., Luben R., Welch A., Bingham S., Wareham N., Day N., et al. Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens 2004, 22:2067-2074.
19. Ferrannini E., Natali A., Capaldo B., Lehtovirta M., Jacob S., Yki-Jarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997, 30:1144-1149.
20. Han T., van Leer E., Seidell J., Lean M. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995, 311:1401-1405.
21. Abbasi F., Brown B., Lamendola C., McLaughlin T., Reaven G. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002, 40:937-943.
22. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G. Insulin resistance and hypersecretion in obesity. European group for the study of insulin resistance (EGIR). J Clin Invest 1997, 100:1166-1173.
23. McLaughlin T., Abbasi F., Lamendola C., Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007, 167:642-648.
24. Farin H.M., Abbasi F., Reaven G.M. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol 2006, 98:1053-1056.
25. Canoy D., Boekholdt S.M., Wareham N., Luben R., Welch A., Bingham S., et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007, 116:2933-2943.
26. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005, 366:1640-1649.
27. Rexrode K.M., Buring J.E., Manson J.E. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord 2001, 25:1047-1056.
28. Tulloch-Reid M.K., Williams D.E., Looker H.C., Hanson R.L., Knowler W.C. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care 2003, 26:2556-2561.
29. Ferrannini E., Balkau B., Coppack S.W., Dekker J.M., Mari A., Nolan J., et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007, 92:2885-2892.
30. Wang J., Thornton J.C., Bari S., Williamson B., Gallagher D., Heymsfield S.B., et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003, 77:379-384.